Lenalidomide maintenance and measurable residual disease in a real-world multiple myeloma transplanted population receiving different treatment strategies guided by access to novel drugs in brazil

HIGHLIGHTS

• who: Anna Beatriz dos Santos Salgado and colleagues from the Internal Medicine Postgraduate Program, Faculty of Medicine, Department of Internal Medicine, University, Federal University of de Janeiro (UFRJ), de Janeiro, Brazil have published the Article: Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil, in the Journal: (JOURNAL)
• what: The authors evaluate the benefits of M-Len and MRD using next-generation flow cytometry (NGF-MRD) at Day + 100 post-ASCT (n = 53). Although the achievement of CR . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.